These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
211 related articles for article (PubMed ID: 1978240)
1. Agonist-induced desensitization of D1-dopamine receptors linked to adenylyl cyclase activity in cultured NS20Y neuroblastoma cells. Barton AC; Sibley DR Mol Pharmacol; 1990 Oct; 38(4):531-41. PubMed ID: 1978240 [TBL] [Abstract][Full Text] [Related]
2. Agonist-induced desensitization of D2 dopamine receptors in human Y-79 retinoblastoma cells. Barton AC; Black LE; Sibley DR Mol Pharmacol; 1991 May; 39(5):650-8. PubMed ID: 1674585 [TBL] [Abstract][Full Text] [Related]
3. Cyclic AMP-mediated desensitization of D1 dopamine receptor-coupled adenylyl cyclase in NS20Y neuroblastoma cells. Black LE; Smyk-Randall EM; Sibley DR Mol Cell Neurosci; 1994 Dec; 5(6):567-75. PubMed ID: 7704430 [TBL] [Abstract][Full Text] [Related]
4. Acute in vivo amphetamine produces a homologous desensitization of dopamine receptor-coupled adenylate cyclase activities and decreases agonist binding to the D1 site. Roseboom PH; Gnegy ME Mol Pharmacol; 1989 Jan; 35(1):139-47. PubMed ID: 2563306 [TBL] [Abstract][Full Text] [Related]
5. Properties of delta opioid receptor in neuroblastoma NS20Y: receptor activation and neuroblastoma proliferation. Law PY; Bergsbaken C J Pharmacol Exp Ther; 1995 Jan; 272(1):322-32. PubMed ID: 7815347 [TBL] [Abstract][Full Text] [Related]
6. The D2S and D2L dopamine receptor isoforms are differentially regulated in Chinese hamster ovary cells. Zhang LJ; Lachowicz JE; Sibley DR Mol Pharmacol; 1994 May; 45(5):878-89. PubMed ID: 7910658 [TBL] [Abstract][Full Text] [Related]
7. Regulation of responsiveness at D2 dopamine receptors by receptor desensitization and adenylyl cyclase sensitization. Bates MD; Senogles SE; Bunzow JR; Liggett SB; Civelli O; Caron MG Mol Pharmacol; 1991 Jan; 39(1):55-63. PubMed ID: 1846220 [TBL] [Abstract][Full Text] [Related]
8. Altered regulation of the D(1) dopamine receptor in mutant Chinese hamster ovary cells deficient in cyclic AMP-dependent protein kinase activity. Ventura AL; Sibley DR J Pharmacol Exp Ther; 2000 May; 293(2):426-34. PubMed ID: 10773012 [TBL] [Abstract][Full Text] [Related]
9. Multiple mechanisms for desensitization of A2a adenosine receptor-mediated cAMP elevation in rat pheochromocytoma PC12 cells. Chern Y; Lai HL; Fong JC; Liang Y Mol Pharmacol; 1993 Nov; 44(5):950-8. PubMed ID: 8246918 [TBL] [Abstract][Full Text] [Related]
10. Persistent activation of the dopamine D1 receptor contributes to prolonged receptor desensitization: studies with A-77636. Lin CW; Bianchi BR; Miller TR; Stashko MA; Wang SS; Curzon P; Bednarz L; Asin KE; Britton DR J Pharmacol Exp Ther; 1996 Mar; 276(3):1022-9. PubMed ID: 8786531 [TBL] [Abstract][Full Text] [Related]
11. Effects of chronic morphine exposure on opioid inhibition of adenylyl cyclase in 7315c cell membranes: a useful model for the study of tolerance at mu opioid receptors. Puttfarcken PS; Werling LL; Cox BM Mol Pharmacol; 1988 May; 33(5):520-7. PubMed ID: 2835651 [TBL] [Abstract][Full Text] [Related]
12. Characterization of dopamine receptors mediating inhibition of adenylate cyclase activity in rat striatum. Onali P; Olianas MC; Gessa GL Mol Pharmacol; 1985 Aug; 28(2):138-45. PubMed ID: 2410769 [TBL] [Abstract][Full Text] [Related]
13. Desensitization of rat striatal dopamine-stimulated adenylate cyclase after acute amphetamine administration. Barnett JV; Kuczenski R J Pharmacol Exp Ther; 1986 Jun; 237(3):820-5. PubMed ID: 2940359 [TBL] [Abstract][Full Text] [Related]
14. Dopamine D1 receptors of the calf parathyroid gland: identification and characterization. Niznik HB; Fogel EL; Chen CJ; Congo D; Brown EM; Seeman P Mol Pharmacol; 1988 Jul; 34(1):29-36. PubMed ID: 2839763 [TBL] [Abstract][Full Text] [Related]
15. Differential modification of striatal D1 dopamine receptors and effector moieties by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline in vivo and in vitro. Hess EJ; Battaglia G; Norman AB; Creese I Mol Pharmacol; 1987 Jan; 31(1):50-7. PubMed ID: 3100940 [TBL] [Abstract][Full Text] [Related]
16. Amygdaloid D1 receptors are not linked to stimulation of adenylate cyclase. Leonard SK; Anderson CM; Lachowicz JE; Schulz DW; Kilts CD; Mailman RB Synapse; 2003 Dec; 50(4):320-33. PubMed ID: 14556237 [TBL] [Abstract][Full Text] [Related]
17. Pharmacological and biochemical characterization of the D-1 dopamine receptor mediating acetylcholine release in rabbit retina. Hensler JG; Cotterell DJ; Dubocovich ML J Pharmacol Exp Ther; 1987 Dec; 243(3):857-67. PubMed ID: 2961878 [TBL] [Abstract][Full Text] [Related]
18. Effects of chronic SCH23390 treatment on the biochemical and behavioral properties of D1 and D2 dopamine receptors: potentiated behavioral responses to a D2 dopamine agonist after selective D1 dopamine receptor upregulation. Hess EJ; Albers LJ; Le H; Creese I J Pharmacol Exp Ther; 1986 Sep; 238(3):846-54. PubMed ID: 3018223 [TBL] [Abstract][Full Text] [Related]
19. Homologous desensitization of the D1A dopamine receptor: efficacy in causing desensitization dissociates from both receptor occupancy and functional potency. Lewis MM; Watts VJ; Lawler CP; Nichols DE; Mailman RB J Pharmacol Exp Ther; 1998 Jul; 286(1):345-53. PubMed ID: 9655879 [TBL] [Abstract][Full Text] [Related]
20. Agonists and antagonists differentially regulate the high affinity state of the D2L receptor in human embryonic kidney 293 cells. Boundy VA; Pacheco MA; Guan W; Molinoff PB Mol Pharmacol; 1995 Nov; 48(5):956-64. PubMed ID: 7476927 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]